EverCommerce Earnings Call Transcripts
Fiscal Year 2026
-
The meeting covered board elections, auditor ratification, and a review of 2025 financials, including 6.4% revenue growth and major strategic moves. AI-driven initiatives are the top priority for 2026, with all proposals approved by shareholders.
-
Q1 2026 revenue grew 3.6% year-over-year to $147.5M, with adjusted EBITDA margin at 27.6%. AI integration and multi-product adoption drove customer expansion, while guidance for 2026 remains unchanged, expecting revenue of $612–632M and adjusted EBITDA of $183–191M.
Fiscal Year 2025
-
Delivered strong Q4 and full-year 2025 results, exceeding guidance with 5.2% revenue growth and robust margins. AI-driven product innovation and operational efficiency are fueling growth, with 2026 guidance reflecting continued investment in AI and payments.
-
After a period of transformation, the business is now focused on scaling its core EverPro and EverHealth verticals, leveraging operational efficiencies, AI-driven product innovation, and improved customer metrics. With strong market positions and significant runway, leadership expects accelerated growth and margin expansion from 2026 onward.
-
Q3 2025 revenue grew 5.3% year-over-year to $147.5 million, with Adjusted EBITDA margin expanding to 31.5%. Strategic focus sharpened by the sale of marketing tech and the Zyratok AI acquisition, supporting long-term growth and margin expansion. Guidance for 2025 was narrowed and raised at the top end.
-
The business is delivering steady growth and high margins, driven by software and payments solutions for service and healthcare markets. Payments and product expansion, organizational transformation, and AI integration are key growth levers, with strong cash flow supporting investments and buybacks.
-
Transformation efforts have driven EBITDA margins above 30% and established strong vertical leadership. With over 720,000 customers, the company is leveraging product-led growth, cross-selling, and AI integration to expand in underpenetrated markets and accelerate growth.
-
Q2 revenue and adjusted EBITDA exceeded guidance, with strong growth in payments and multi-product adoption. Full-year EBITDA guidance was raised, while revenue guidance remains prudent despite robust first-half results. AI initiatives and operational efficiencies continue to drive margin expansion.
-
Q1 2025 revenue and adjusted EBITDA exceeded guidance, with strong payments growth and margin expansion. Guidance for 2025 remains unchanged, supported by resilient end markets and ongoing transformation initiatives. Share repurchase authorization was increased and extended.
-
EverPro and EverHealth now drive most revenue, with payments and product integration as key growth levers. Leadership consolidation and operational improvements have boosted margins, while a large greenfield market and enhanced customer engagement support future expansion.
Fiscal Year 2024
-
Q4 2024 revenue and adjusted EBITDA exceeded guidance, with strong customer growth and margin expansion. Strategic divestitures and leadership changes position the business as a focused SaaS and payments platform, with 2025 guidance reflecting continued operations and robust free cash flow.
-
The business is undergoing a strategic transformation, focusing on home and health services, with leadership changes and divestitures to drive efficiency and growth. Payments and cross-sell initiatives are key to boosting high-margin revenue, while macro trends and reinvestment support a path to mid-teens growth and strong profitability.
-
Q3 2024 revenue and adjusted EBITDA exceeded guidance, with strong payments growth and margin expansion. Transformation and optimization initiatives advanced, including EverPro reorganization and cost-saving measures, while customer enablement for multiple solutions grew 25% year-over-year.
-
The event highlighted ongoing transformation and optimization efforts aimed at reaccelerating growth and improving margins, with a focus on cross-selling high-margin products like payments and EverPro Edge. Leadership transition will maintain strategic continuity, while disciplined M&A and infrastructure upgrades support future expansion.
-
Q2 2024 revenue and adjusted EBITDA exceeded guidance, with strong payments growth and margin expansion. Transformation and optimization initiatives advanced, EverHealth consolidation delivered improved metrics, and capital allocation focused on buybacks. Guidance for 2024 remains unchanged.
-
Serving 690,000 SMBs, the company has evolved from digital payments to vertically tailored business management solutions, driving growth through acquisitions and a land-and-expand model. Despite macro headwinds in MarTech, core SaaS and payments remain resilient, with double-digit growth targeted as transformation and product consolidation continue.